FDA Person
FDAGabrielle J. Swain
View detailed information about Gabrielle J. Swain, including compliance records, violations, and related data.
Person Profile
FDA investigator. Took part in 66 inspections of 59 companies, 2023–2026.
Inspections (66)
| Date | Company | Classification | Project area | Inspection |
|---|---|---|---|---|
| September 28, 2026 | John Khoury, M.D. | Not classified | Bioresearch Monitoring | #1338418 |
| September 18, 2026 | Avanthi, LLC | Not classified | #1338416 | |
| August 28, 2026 | Incyte Corporation | Not classified | #1333950 | |
| August 6, 2026 | First Institute of All Medicine | Not classified | Project Evaluation: Devices | #1329818 |
| August 5, 2026 | First All-Med IRB | Not classified | Project Evaluation: Devices | #1325612 |
| July 21, 2026 | Taisei Kobayashi, MD | Not classified | #1331756 | |
| June 12, 2026 | Sun Young Rha, M.D., Ph.D. | Not classified | #1324668 | |
| June 5, 2026 | Ying Liu, M.D. | Not classified | #1323808 | |
| May 21, 2026 | Robert Sarsfield, DVM | Not classified | #1323180 | |
| May 15, 2026 | Coby E Rudakewiz DVM | Not classified | #1319326 | |
| May 8, 2026 | Madrigal Pharmaceutical, Inc | Not classified | #1322984 | |
| April 22, 2026 | Clario (BioClinica, Inc.) | Not classified | #1318274 | |
| February 23, 2026 | Clario (BioClinica, Inc.) | Not classified | #1314940 | |
| January 23, 2026 | Gautam T. Jayram, M.D. | VAI | Bioresearch Monitoring: Human Drugs | #1300030 |
| December 4, 2025 | Cooper Health System IRB | Not classified | #1294644 | |
| November 3, 2025 | Kachiu Lee, MD | NAI | Bioresearch Monitoring | #1291624 |
| October 17, 2025 | Wills Eye Hospital IRB | Not classified | #1291014 | |
| September 12, 2025 | Balkis Meddeb, M.D. | Not classified | #1285688 | |
| September 5, 2025 | Khaldoun Ben Hamda MD | NAI | Bioresearch Monitoring | #1287036 |
| August 26, 2025 | Clario (BioClinica, Inc.) | Not classified | #1281934 |
Documents (15)
- 483 · Vincent DiGiovanni, DO · August 18, 2025
- 483 · Hummayun Ismail, M.D. · August 1, 2025
- 483 · Gautam T. Jayram, M.D. · January 23, 2026
- 483 · DERMDOX CENTERS FOR DERMATOLOGY · January 21, 2021
- 483 · Charles River Laboratories Inc. · March 15, 2024
- 483 · Wills Eye Hospital IRB · October 17, 2025
- 483 · Gene Logic, Inc. · March 25, 2024
- 483 · Enrico Bertini MD · May 5, 2023
- EIR · Pfizer, Inc. · April 19, 2023
- EIR · Janssen Biotech Inc. · September 24, 2024
- 483 · Acrotech Biopharma Inc. · January 19, 2023
- 483 · Adam Peyton, D.O. · October 26, 2023
- 483 · Enrico Bertini MD · May 9, 2025
- 483 · Charles River Laboratories Inc. · March 15, 2024
- 483 · Cooper Health System IRB · December 4, 2025
Person Information
Name
Gabrielle J. Swain
Title
investigator
Role
COMPANY REP
ID: 55f33430-41dc-4fae-bac0-ec6ea340feb6
Get More Insights
Access our comprehensive quality intelligence platform to analyze patterns, track compliance trends, and stay ahead of regulatory changes.
1.5M+ regulatory data points
Real-time compliance monitoring
Interactive analytics dashboard
Looking for more people? Our platform provides access to thousands of FDA people with advanced search and filtering capabilities.
Transform Regulatory Data into Actionable Intelligence
Join leading pharmaceutical and medical device companies who trust KeyPedia for their regulatory compliance needs.